Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dillon

Showing results (421-430 of 433) with videos related to

Pageof 44
Sort By:
Allergy|March 14, 2020
The international sinonasal microbiome study: A multicentre, multinational characterization of sinonasal bacterial ecologySathish Paramasivan, Ahmed Bassiouni, Arron Shiffer, et al.
Science Translational Medicine|October 8, 2020
ICOSL<sup>+</sup> plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonistDjamilatou Adom, Stacey R Dillon, Jinfeng Yang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune DiseasesLawrence S Evans, Katherine E Lewis, Daniel DeMonte, et al.
Frontiers in Cellular and Infection Microbiology|April 24, 2020
Microbiotyping the Sinonasal MicrobiomeAhmed Bassiouni, Sathish Paramasivan, Arron Shiffer, et al.
Nature Immunology|June 9, 2004
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in miceStacey R Dillon, Cindy Sprecher, Angela Hammond, et al.
Journal of Medicinal Chemistry|August 30, 2011
Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary diseasePaul A Glossop, Christine A L Watson, David A Price, et al.
Plos Computational Biology|June 24, 2021
Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshopsMatthew R Dillon, Evan Bolyen, Anja Adamov, et al.
JAMA|February 7, 2024
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical TrialHooman Kamel, W T Longstreth, David L Tirschwell, et al.
Nature|November 18, 2000
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte functionJ Parrish-Novak, S R Dillon, A Nelson, et al.
Stroke|July 28, 2020
National Institutes of Health StrokeNet During the Time of COVID-19 and BeyondJoseph P Broderick, Jordan J Elm, L Scott Janis, et al.
Pageof 44

Showing results (421-430 of 433) with videos related to

Sort By:
Pageof 44
Allergy|March 14, 2020
The international sinonasal microbiome study: A multicentre, multinational characterization of sinonasal bacterial ecologySathish Paramasivan, Ahmed Bassiouni, Arron Shiffer, et al.
Science Translational Medicine|October 8, 2020
ICOSL<sup>+</sup> plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonistDjamilatou Adom, Stacey R Dillon, Jinfeng Yang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune DiseasesLawrence S Evans, Katherine E Lewis, Daniel DeMonte, et al.
Frontiers in Cellular and Infection Microbiology|April 24, 2020
Microbiotyping the Sinonasal MicrobiomeAhmed Bassiouni, Sathish Paramasivan, Arron Shiffer, et al.
Nature Immunology|June 9, 2004
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in miceStacey R Dillon, Cindy Sprecher, Angela Hammond, et al.
Journal of Medicinal Chemistry|August 30, 2011
Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary diseasePaul A Glossop, Christine A L Watson, David A Price, et al.
Plos Computational Biology|June 24, 2021
Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshopsMatthew R Dillon, Evan Bolyen, Anja Adamov, et al.
JAMA|February 7, 2024
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical TrialHooman Kamel, W T Longstreth, David L Tirschwell, et al.
Nature|November 18, 2000
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte functionJ Parrish-Novak, S R Dillon, A Nelson, et al.
Stroke|July 28, 2020
National Institutes of Health StrokeNet During the Time of COVID-19 and BeyondJoseph P Broderick, Jordan J Elm, L Scott Janis, et al.
Pageof 44